Plus Therapeutics (PSTV) Misses Q2 EPS by 71c

Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.71). Revenue for the quarter came in at $1.27 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays
• Pullback in chip stocks is a buying opportunity, Citi says
• American Express down 2% in premarket trade after Q2 revenue miss offsets EPS beat